Vivo Ventures V, LLC
CIK 1399028 · last filed 2019-11-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
7
Total Filings
18
Lifetime Open-Market Net
-$30.90M
Filer Profile
Reported Address
505 HAMILTON AVENUE, SUITE 200PALO ALTO, CA 94301
Phone
(650) 688-0818
State of Incorporation
DE
Related Filers
Vivo Ventures Fund V, L.P. — 29 joint filings, latest 2019-12-03
Vivo Ventures V Affiliates Fund, L.P. — 29 joint filings, latest 2019-12-03
BIOASIA MANGEMENT LLC — 2 joint filings, latest 2014-11-20
BIOTECHNOLOGY DEVELOPMENT FUND II LP — 2 joint filings, latest 2014-11-20
Biotechnology Development Fund IV Affiliates LP — 2 joint filings, latest 2014-11-20
Frank Kung — 2 joint filings, latest 2014-11-20
VIVO VENTURES VII, LLC — same reported address
Vivo Capital Fund VIII, L.P. — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.
View filings on SEC EDGAR.
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC (SLNO) Delisted | 10%+ Owner | 245,727 | $53.01 | $13.03M | -$931.9K | 3 | 2019-11-25 |
| SOLENO THERAPEUTICS INC (SLNOW) Delisted | 10%+ Owner | 4,219,504 | — | — | $6.00M | 4 | 2018-08-09 |
| SOLENO THERAPEUTICS INC (CAPNW) Delisted | 10%+ Owner | 179,260 | — | — | $0 | 1 | 2017-04-14 |
| Sagent Pharmaceuticals, Inc. (SGNT) Delisted | 10%+ Owner | 2,978,803 | — | — | -$34.44M | 2 | 2016-04-25 |
| SOLENO THERAPEUTICS INC (CAPN.W) Delisted | 10%+ Owner | 6,922,123 | — | — | $0 | 1 | 2016-02-09 |
| Lite Strategy, Inc. (MEIP) Delisted | 10%+ Owner | 9,645 | $3.20 | $30.9K | -$1.53M | 5 | 2015-11-09 |
| ALBIREO PHARMA, INC. (BIOD) Delisted | 10%+ Owner | 56,188 | — | — | $0 | 1 | 2007-05-18 |
Recent Filings · Page 2 of 2
18 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-02-09 | SOLENO THERAPEUTICS INC (CAPN.W) Delisted | Other (J) | +408,672 | $0 | EDGAR |
| 2015-11-09 | Lite Strategy, Inc. (MEIP) Delisted | Sell (S) | −22,693 | -$41.9K | EDGAR |
| 2015-03-26 | Lite Strategy, Inc. (MEIP) Delisted | O | +26,445 | $82.5K | EDGAR |
| 2013-10-29 | Lite Strategy, Inc. (MEIP) Delisted | Sell (S) | −52,221 | -$428.9K | EDGAR |
| 2013-10-03 | Lite Strategy, Inc. (MEIP) Delisted | Sell (S) | −101,382 | -$1.03M | EDGAR |
| 2013-09-17 | Sagent Pharmaceuticals, Inc. (SGNT) Delisted | Sell (S) | −1,617,051 | -$34.36M | EDGAR |
| 2013-05-20 | Lite Strategy, Inc. (MEIP) Delisted | Sell (S) | −3,036 | -$27.5K | EDGAR |
| 2007-05-18 | ALBIREO PHARMA, INC. (BIOD) Delisted | Conv (C) | +1,078,933 | $0 | EDGAR |
Showing 11–18 of 18
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.